Intravenous infusion dosage form
US10869867B2 · kind B2 · utility
1Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2016 |
| Grant date | Dec 22, 2020 |
| Priority date | — |
| Expiry date | Apr 7, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M5/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an intravenous infusion dosage form of pemetrexed or its pharmaceutically acceptable salt, having long term stability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.